Acadia Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€27.40
Target price
19.12.24
€36.48
Performance (%)
-37.15%
Price
30.07.24
€17.22
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Acadia Pharmaceuticals is performing very badly with a performance of -37.15%. This prediction currently runs until 19.12.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 5.579% | 5.579% |
iShares Core DAX® | -0.621% | 1.080% |
iShares Nasdaq 100 | -4.503% | -5.432% |
iShares Nikkei 225® | -2.562% | -1.617% |
iShares S&P 500 | -1.706% | -1.223% |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $40.00 price target on the stock, up previously from $31.00.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.27
12.07.24
12.07.24
€25.68
12.07.25
12.07.25
5.84%
30.07.24
30.07.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.30
18.03.24
18.03.24
€27.59
18.03.25
18.03.25
-0.46%
30.07.24
30.07.24